Search for: "Pfizer Corporation"
Results 121 - 140
of 819
Sort by Relevance
|
Sort by Date
13 Jan 2020, 12:04 pm
The New Times characterized the best “corporate citizens” award by Corporate responsibility (CR) Magazine as “extremely dubious. [read post]
4 Oct 2019, 10:59 am
Pfizer, Inc., 457 N.J. [read post]
18 Sep 2019, 6:35 am
District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a ‘fair share’ of the generic drug market and avoid price-lowering competition. [read post]
17 Sep 2019, 9:37 am
Department of the Interior), Lourdes Delgado (Pfizer) and Zach Ulrich (Colorado Student Loan Ombudsperson). [read post]
12 Sep 2019, 5:44 pm
In 2017, Pfizer Inc. [read post]
10 Sep 2019, 8:03 pm
More recently, in Pfizer, Inc. v Arch Ins. [read post]
23 Aug 2019, 6:00 am
Pfizer Inc. v. [read post]
13 Aug 2019, 11:52 am
Accordingly, there are multiple liaisons on the committee: Coalition of Federal Ombudsman Liaison: Ken Skodacek [Clinical Trials Program and Payor Communication Task Force at CDRH/FDA]Corporate Organization Ombudsman Roundtable Liaison: Elizabeth Lopez [Manager Ombudsman at Pfizer]International Ombudsman Association Liaison: Katie Swanson [Former Extern, University of California, Irvine Office of the Ombudsman; Operations Support Specialist at Air New Zealand]United States… [read post]
30 Jul 2019, 4:37 am
The Washington Post reports that a decision by Pfizer to not pursue a “costly clinical trial” to verify the effect “the company’s blockbuster rheumatoid arthritis therapy Enbrel” could have on Alzheimer’s disease shows how determinations “made by industry executives – who are ultimately accountable to shareholders – can have impact well beyond corporate board rooms. [read post]
28 Jul 2019, 10:23 am
Pfizer is a Delaware corporation with its principal place of business in New York. [read post]
26 Jul 2019, 11:18 am
| TILTing Perspectives 2019 | Book review: Public rights – Copyright’s Public Domains | The Agreement on African Continental Free Trade Area (AfCFTA) - Protocol on IP | Lycra owner gets in a tight spot on costs: Unjust Part 36 offers, ex employees, breach of confidence & more | Book Review: Intellectual Property, Finance and Corporate Governance | IP law in Cambridge this summer [read post]
31 May 2019, 8:39 am
Pfizer, Inc., 2016 WL 4548101, at *5 (Del. [read post]
20 Mar 2019, 8:15 am
An unlikely anti-death penalty movement has arisen in the corporate world as a result. [read post]
5 Mar 2019, 9:38 am
Media reports of the Senate Finance hearing called it “political theater,” and it offered lawmakers a chance to vent at execs from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer, and Sanofi. [read post]
1 Jan 2019, 5:10 pm
In addition, the drug manufacturer Pfizer paid approximately $23.85 million to resolve claims that it used a foundation as a conduit to pay the co-pays of Medicare patients taking Pfizer drugs. [read post]
7 Dec 2018, 3:00 am
The new project is being led by the IIRC’s Corporate Reporting Dialogue. [read post]
19 Jul 2018, 9:01 pm
Hogan released tax returns that show he has made about $2.4 million in corporate earnings while governor. [read post]
5 Jul 2018, 7:20 am
’Additionally, in Pfizer Inc. v. [read post]
5 Jul 2018, 7:20 am
’Additionally, in Pfizer Inc. v. [read post]
8 Jun 2018, 12:32 pm
Numerous False Claims Act cases alleging unlawful waivers and similar schemes have resulted in successful settlements: Last month, Pfizer agreed to pay $24 million and enter a corporate integrity agreement to resolve False Claims Act claims that it unlawfully induced Medicare patients to use three of its drugs by illegitimately covering patients copays. [read post]